Stockscreener 앱 받기
48.55
0.61%
-0.30
시간 외 거래:
48.49
-0.06
-0.12%
전일 마감가:
$48.85
열려 있는:
$49.45
하루 거래량:
20.19M
Relative Volume:
1.10
시가총액:
$72.16B
수익:
$20.62B
순이익/손실:
$3.56B
주가수익비율:
20.36
EPS:
2.3847
순현금흐름:
$3.48B
1주 성능:
+0.50%
1개월 성능:
-13.27%
6개월 성능:
-50.22%
1년 성능:
-52.79%
1일 변동 폭
$48.27
$50.14
1주일 범위
$47.16
$50.14
52주 변동 폭
$47.16
$109.50
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
48.55 | 72.61B | 20.62B | 3.56B | 3.48B | 2.3847 |
ABT
Abbott Laboratories
|
91.07 | 158.12B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.66 | 115.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
81.67 | 105.19B | 36.36B | 4.84B | 5.43B | 3.7212 |
EW
Edwards Lifesciences Corp
|
85.96 | 50.35B | 6.30B | 1.07B | 1.09B | 1.8406 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-30 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-09-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 개시 | Leerink Partners | Outperform |
| 2025-04-16 | 업그레이드 | Needham | Hold → Buy |
| 2025-01-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-10-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-20 | 재개 | Citigroup | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-06 | 개시 | Wolfe Research | Outperform |
| 2022-05-27 | 업그레이드 | Needham | Hold → Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Buy |
| 2019-12-30 | 재확인 | Cowen | Outperform |
| 2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-09-05 | 재개 | JP Morgan | Overweight |
| 2019-09-03 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-10-02 | 재확인 | Morgan Stanley | Overweight |
| 2018-09-07 | 재확인 | Needham | Strong Buy |
| 2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-07-06 | 재확인 | Needham | Strong Buy |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
Boston Scientific Corp (CHIX:BSXd) Competitors 2026 - GuruFocus
Boston Scientific Corp Stock Operating Data - GuruFocus
Boston Scientific Corp (CHIX:BSXd) Stock Price, Trades & News - GuruFocus
Is Boston Scientific Corporation (BSX) One of the Top Cheap Stocks With Strong Buy Ratings on Wall Street? - Insider Monkey
How Investors May Respond To Boston Scientific (BSX) Strong Q1 Beat But Cut Guidance On Watchman Growth - Yahoo Finance
$BSX StockBoston Scientific Corp | Quick Financials | LAST 12 YEARS Fulham Vs Bournemouth (HNvQmq85Ml) - Mshale
Boston Scientific stock: Is BSX underperforming the healthcare sector? - MSN
Truist cuts Boston Scientific stock price target on Watchman slowdown - Investing.com UK
Boston Scientific (BSX) Rises Higher Than Market: Key Facts - Yahoo Finance
Boston Scientific Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
BSX Stock Quote Price and Forecast - CNN
Boston Scientific Corp. stock (US10117L1017): Indiana expansion and sector backdrop in focus - AD HOC NEWS
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet - Yahoo Finance
Boston Scientific plans to build $138M facility, hire 300 in Plainfield - Inside INdiana Business
Marietta medical startup gets $1.5 billion investment from Boston company - The Business Journals
UPDATE: Boston Scientific plans to build $138M facility, hire 300 in Plainfield - Indianapolis Business Journal
Boston Scientific (BSX): Company Profile, Stock Price, News, Rankings - Fortune
Why Boston Scientific Faces New Questions Across Healthcare - Kalkine Media
BTIG cuts Boston Scientific stock price target on Watchman sales outlook - Investing.com Nigeria
How A Quiet Reset Is Shaping The Boston Scientific (BSX) Investment Story - Yahoo Finance
FRACTURE IDE Success Adds Clinical Support To Boston Scientific Valuation Case - Yahoo Finance
Peripheral Vascular Devices Market by Type, End User - GlobeNewswire Inc.
Deals tracker: Ohio hospital, OhioHealth drop merger plans - Modern Healthcare
Boston Scientific Stock: Is BSX Underperforming the Healthcare Sector? - Barchart
Why Did BSX, LOW, CAG Fall To 52-Week Lows Today? - TradingView
Spotting Winners: Boston Scientific (NYSE:BSX) And Medical Devices & SuppliesDiversified Stocks In Q1 - Yahoo Finance
Boston Scientific (NYSE: BSX) CEO gifts 386,755 shares to irrevocable trust - Stock Titan
Jim Cramer Comments On Boston Scientific and Other Medical Equipment Makers - Yahoo Finance
Wolfe Research Downgrades Boston Scientific Corporation (BSX) To Peer Perform - Insider Monkey
Canaccord lowers Boston Scientific stock price target on Watchman slowdown - Investing.com
BSX Stock Price, Quote & Chart | BOSTON SCIENTIFIC CORP (NYSE:BSX) - ChartMill
Why Did BSX, LI, ROL Stocks Fall To 52-Week Lows On Friday? - TradingView
Boston Scientific Corp. stock (US10117L1017): Wolfe Research downgrade in focus as shares trade near - AD HOC NEWS
Zscaler, AutoZone, And Regencell Are Among Top 10 Large-Cap Losers Last Week (May 25-May 29): Are The Others In Your Portfolio? - Benzinga
BSX Stock | Boston Scientific Corp Q3 2021 Earnings Call Frederik Andersen (UDFIjtx214) - Mshale
Boston Scientific Corp (NYSE:BSX): A Decent Value Play with Strong Fundamentals and an Attractive Valuation - ChartMill
Boston Scientific (BSX) Valuation Reset After Watchman Growth Concerns And Intensifying Competition - Yahoo Finance
Boston Scientific (BSX) Experiences Significant Options Activity on Thursday - GuruFocus
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Unusual Options Activity Points to Boston Scientific Stock as a Hot M&A Target - Barchart.com
Boston Scientific Corp ($BSX) Q2 2025 Earnings Call Slushi Twist (3k72Vx1f7J) - Mshale
Boston Scientific Corp. stock underperforms Monday when compared to competitors - MSN
BSX Downgraded by Wolfe Research -- Rating Changed to Peer Perfo - GuruFocus
BSX vs. ABT: Which Medical Stock Has More Upside Potential? - TradingView
Wolfe Research cuts Boston Scientific rating as key growth drivers falter - Investing.com Nigeria
Wolfe Research downgrades Boston Scientific stock rating on growth concerns - Investing.com
Boston Scientific’s $1.5B bet signals heart valve market battle - Modern Healthcare News
Why Boston Scientific Stock Was Sliding This Week - The Motley Fool
Barclays Remains a Buy on Boston Scientific (BSX) - The Globe and Mail
Our Boston Scientific Pick Has Suffered. We’re Pulling the Recommendation. - Barron's
Federated Hermes Kaufmann Fund II's Boston Scientific Corp(BSX) Holding History - GuruFocus
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.70%
1.35%
자본화:
|
볼륨(24시간):